IOBT: IO Biotech Corp Net earnings per share (EPS TTM)

IO Biotech (IOBT) - corporate logo

IO Biotech, Inc. (IOBT) develops innovative vaccines against melanoma and solid tumors, mitigating risks through partnerships with pharmaceutical behemoths. The current rolling annual EPS value on this GURU.Markets platform chart has reached -0.23. Drug delivery is ensured via strict temperature control through air carriers. However, the absence of commercial products leaves the company dependent on external financing and the results of clinical trials.

IOBT IO Biotech, Inc. Net earnings per share for the last 12 months (07/04/2022 - 04/18/2026)

Summary analytical data breakdowns for IO Biotech Inc (IOBT)

- share price and expert price forecast:
Stock Quotes IO Biotech, Inc.|IOBT - Fair Value Consensus
- market capitalization information:
Market Capitalization IO Biotech, Inc.|IOBT - Company Buyout Price
- business book valuation details:
Net Assets per Single Share IO Biotech|IOBT - Company Net Assets|Market Value to Book Value Ratio iobiotech.com|IOBT - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio IO Biotech, Inc.|IOBT - Long-Term Debt to Capital|Short-Term Debt to Equity IO Biotech Corp|IOBT - Company Aggregate Debt|Debt to Book Capitalization Ratio IO Biotech, Inc.|IOBT - Long-Term Debt|Company Current Liabilities IO Biotech|Quick Liquidity Indicator iobiotech.com
- earnings and multiples data:
IOBT - Profit After Payment of Taxes|Projected Future Earnings IO Biotech, Inc.|IOBT - Company Value to Net Income|Forward P/E Multiple IO Biotech|IOBT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IO Biotech, Inc.|IOBT - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) IO Biotech|IOBT - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months iobiotech.com|IOBT - Earnings per share trend in current year|Expected earnings per share growth for next year IO Biotech, Inc.
Fundamental valuation:IOBT - IO Biotech, Inc.
Flagship merchandise of IO Biotech Corp

To objectively assess the operational efficiency of IO Biotech, Inc. (IOBT), investors must analyze real returns adjusted for the impact of share issuances. This rolling annual earnings per share snapshot reflects net profit over 12 months, allowing for a correlation between anti-tumor vaccine development costs and the company's capitalization to determine the long-term investment attractiveness of its innovative approach.

Main competitors

IBRX: Net earnings per share for the last 12 months|Earnings per share for the trailing year IMCR (immunocore.com)|JANX: Net earnings per share (EPS TTM)|RCUS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Zymeworks Corp|Net earnings per share for the last 12 months Tango Therapeutics Corp (TNGX)|Earnings per share for the last twelve months Iovance Biotherapeutics (IOVA)|Net earnings per share for the last 12 months immatics.com IMTX|Xencor - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Compass Therapeutics Inc CMPX|REPL - Earnings per share for the last twelve months|LYEL (Lyell Pharma) - Earnings per share for the last 12 months|Innate Pharma S.A. (IPHA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Pyxis Oncology (PYXS)|Net earnings per share for the last 12 months CGEN|STRO - Net earnings per share for the trailing year|Net earnings per share for the last 12 months INKT (MiNK)|Earnings per share for the last four quarters HOWL|Net earnings per share (EPS TTM) IMMX (Immix Biopharma)|Earnings per share for the trailing year ALXO|Cue Biopharma, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months PDS Biotechnology|sonnetbio.com (SONN) - Earnings per share for the last twelve months|MAIA Bio - Earnings per share for the trailing year|LIMN (Liminatus Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Lava Tx|Earnings per share for the last twelve months NextCure (NXTC)|LPTX: Earnings per one share for the last 12 months|Intensity Therapeutics, Inc. - Net earnings per share for the last 12 months|Sensei Biotherapeutics Inc (SNSE) - Net earnings per one share for the last twelve months|Theriva Biologics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Gritstone bio, Inc. GRTS|Kineta (KA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months NexImmune Inc (NEXI)|Net earnings per share for the last 12 months TSBX|VCNX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) HARP